Photo of Che-Kai Tsao
Accepting New Patients
Che-Kai Tsao, MD
Hematology-Oncology
    • Position
    • ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
    • Specialties
    • Hematology-Oncology
    • Oncology (Cancer)
    • Languages
    • Chinese (Mandarin)
    • English
    • Spanish
    • Taiwanese
    • Hospital Affiliations
    • Mount Sinai Queens
    • The Mount Sinai Hospital
    • Phone
    • Ruttenberg Treatment Center 212-241-6756
    • Mount Sinai Queens Infusion Center 718-808-7372
Request an Appointment
1470 Madison Avenue 3rd floor
New York, NY 10029
Phone: 212-241-6756
Che-Kai Tsao, MD is an Assistant Professor of Medicine, Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai and is on staff at the Tisch Cancer Institute of the Mount Sinai Hospital and the Mount Sinai Queens Infusion Center. He received his medical degree from SUNY Downstate Medical Center. He then completed a residency program in internal medicine at Long Island Jewish Medical Center of Albert Einstein College of Medicine followed by a fellowship in Hematology/Oncology at Mount Sinai. There he served as Chief Fellow and was recognized with the 2012 Mount Sinai Physician of the Year, Fellow award.

Dr. Tsao is a board certified in internal medicine, hematology, and medical oncology. His clinical interests includes the treatment of solid tumors, including breast, lung, gastrointestinal, genitourinary, and gynecologic cancers. He is also interested in the treatment of blood disorders including, anemia, bleeding and clotting disorders, as well as malignant hematologic diseases. Dr. Tsao is passionate about offering the latest advances in cancer treatment to his patients. He practices at the Mount Sinai Queens Infusion Center on the campus of Mount Sinai Queens.

Dr. Tsao is actively involved in research on the development of novel therapies in the treatment of genitourinary cancers. He is the recipient of several Merit Awards given by the American Society of Clinical Oncology. His main focus is in defining clinical and molecular phenotype of prostate, kidney, and bladder cancers, as well as novel therapies in those disease states. He is a lead investigator in several ongoing clinical trials and has authored over 40 peer-reviewed publications.

Dr. Tsao is also a member of the American Society of Clinical Oncology, the American Association of Oncology Research, and the American Society of Hematology.

Certifications

Hematology
Medical Oncology
American Board of Internal Medicine

Education

MD, SUNY Downstate Medical Center

Residency, Internal Medicine
Long Island Jewish Medical Center

Fellowship, Hematology/Oncology
Mount Sinai Hospital

Languages

Chinese (Mandarin), English, Spanish, Taiwanese